184 related articles for article (PubMed ID: 28627758)
1. Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer.
Nigjeh EN; Chen R; Allen-Tamura Y; Brand RE; Brentnall TA; Pan S
Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28627758
[TBL] [Abstract][Full Text] [Related]
2. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.
Pan S; Chen R; Tamura Y; Crispin DA; Lai LA; May DH; McIntosh MW; Goodlett DR; Brentnall TA
J Proteome Res; 2014 Mar; 13(3):1293-306. PubMed ID: 24471499
[TBL] [Abstract][Full Text] [Related]
3. Effect of intraoral mechanical stress application on the expression of a force-responsive prognostic marker associated with system disease progression.
Zhang Y; Kou X; Jiang N; Liu Y; Tay FR; Zhou Y
J Dent; 2017 Feb; 57():57-65. PubMed ID: 27979689
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in pancreatic ductal adenocarcinoma.
Waragai Y; Suzuki R; Takagi T; Sugimoto M; Asama H; Watanabe K; Kikuchi H; Hikichi T; Masamune A; Kang Y; Fleming JB; Ohira H
Pancreatology; 2016; 16(6):1044-1050. PubMed ID: 27665173
[TBL] [Abstract][Full Text] [Related]
6. Serum retinol binding protein 4 and galectin-3 binding protein as novel markers for postmenopausal nonalcoholic fatty liver disease.
Cai H; Lu S; Chen Y; Das Mbbs Mrcog S; Niu Z; Zhuo G; Lai L; Zhang Z
Clin Biochem; 2018 Jun; 56():95-101. PubMed ID: 29679552
[TBL] [Abstract][Full Text] [Related]
7. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
Pan S; Chen R; Crispin DA; May D; Stevens T; McIntosh MW; Bronner MP; Ziogas A; Anton-Culver H; Brentnall TA
J Proteome Res; 2011 May; 10(5):2359-76. PubMed ID: 21443201
[TBL] [Abstract][Full Text] [Related]
8. Serum N-Glycome analysis reveals pancreatic cancer disease signatures.
Vreeker GCM; Hanna-Sawires RG; Mohammed Y; Bladergroen MR; Nicolardi S; Dotz V; Nouta J; Bonsing BA; Mesker WE; van der Burgt YEM; Wuhrer M; Tollenaar RAEM
Cancer Med; 2020 Nov; 9(22):8519-8529. PubMed ID: 32898301
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Proteomics Based on Optimized Data-Independent Acquisition in Plasma Analysis.
Nigjeh EN; Chen R; Brand RE; Petersen GM; Chari ST; von Haller PD; Eng JK; Feng Z; Yan Q; Brentnall TA; Pan S
J Proteome Res; 2017 Feb; 16(2):665-676. PubMed ID: 27995795
[TBL] [Abstract][Full Text] [Related]
10. Evidence of Altered Glycosylation of Serum Proteins Prior to Pancreatic Cancer Diagnosis.
Krishnan S; Whitwell HJ; Cuenco J; Gentry-Maharaj A; Menon U; Pereira SP; Gaspari M; Timms JF
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232830
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.
White MJ; Roife D; Gomer RH
J Immunol; 2015 Aug; 195(4):1858-67. PubMed ID: 26136428
[TBL] [Abstract][Full Text] [Related]
12. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
[TBL] [Abstract][Full Text] [Related]
13. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
[TBL] [Abstract][Full Text] [Related]
14. Glycoproteins and glycoproteomics in pancreatic cancer.
Pan S; Brentnall TA; Chen R
World J Gastroenterol; 2016 Nov; 22(42):9288-9299. PubMed ID: 27895417
[TBL] [Abstract][Full Text] [Related]
15. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.
Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM
PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074
[TBL] [Abstract][Full Text] [Related]
16. Data independent acquisition of plasma biomarkers of response to neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma.
O'Rourke MB; Sahni S; Samra J; Mittal A; Molloy MP
J Proteomics; 2021 Jan; 231():103998. PubMed ID: 33027703
[TBL] [Abstract][Full Text] [Related]
17. Developments in serologic detection of human pancreatic adenocarcinoma.
Eskelinen M; Haglund U
Scand J Gastroenterol; 1999 Sep; 34(9):833-44. PubMed ID: 10522599
[No Abstract] [Full Text] [Related]
18. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
19. Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer.
Grassadonia A; Tinari N; Natoli C; Yahalom G; Iacobelli S
Dis Markers; 2013; 35(6):747-52. PubMed ID: 24347795
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.
Sogawa K; Takano S; Iida F; Satoh M; Tsuchida S; Kawashima Y; Yoshitomi H; Sanda A; Kodera Y; Takizawa H; Mikata R; Ohtsuka M; Shimizu H; Miyazaki M; Yokosuka O; Nomura F
Br J Cancer; 2016 Oct; 115(8):949-956. PubMed ID: 27657339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
